Merit Medical closes C2 CryoBalloon acquisition from PENTAX Medical

MERIT MEDICAL SYSTEMS INC

Acquired C2 CryoBalloon device and related technology from Pentax of America, Inc., a subsidiary of PENTAX Medical.
Transaction closed on November 3, 2025; definitive asset purchase agreement signed October 17, 2025.
Financial terms of the acquisition were not disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.